Live
- BJP releases ‘charge sheet’ against BJD govt
- District Nodal Officer Venkataramana announced the intermediate results
- She team that stopped child marriages
- Medical devices sector needs separate rules, says industry body AiMeD
- Andhra Paper declares lockout
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
Visakhapatnam: KGH, AMC to conduct phase II, III of clinical trials
The Government of Andhra Pradesh has approved to conduct two clinical trials in Andhra Medical College/King George Hospital
Visakhapatnam: The Government of Andhra Pradesh has approved to conduct two clinical trials in Andhra Medical College/King George Hospital.
According to the communication received from the Directorate of Medical Education, Vijayawada, phase II clinical trial was involved in usage of CRO Navitas Life Sciences 2-Deoxy- D-Glucose as an adjunctive therapy to standard of care of acute treatment of moderate to severe Covid-19 cases.
The study has the support of DRDO. Y Gyana Sundar Raju of General Medicine was appointed as principal investigator for the study.
Similarly, phase-III single blind randomized control study will be conducted to determine the safety and immunogenicity of the coronavirus disease vaccine – Covishield vaccine of Serum Institute of India. The study was supported by ICMR. Professor of Community Medicine B Devi Madhavi was appointed as principal investigator for the trial.
A team of experts from various departments are co-investigators for the studies.
